In a bold move today, USPTO Director John A. Squires issued an open letter announcing the return of institution decisions for Inter Partes Reviews (IPRs) and Post-Grant Reviews (PGRs) to the Director's office, as per 35 U.S.C. §§ 314 and 324. This reverses the long-standing delegation to the Patent Trial and Appeal Board (PTAB), aligning with the America Invents Act's intent to promote fair innovation and intellectual property protection.

Key Highlights from the Letter

  • Under the America Invents Act (AIA), Congress explicitly vested this authority in the USPTO Director, allowing delegation but not exclusively.
  • Past delegation raised concerns in patent law, including perceived self-incentivization (PTAB "filling its own docket"), bifurcated procedures leading to sky-high institution rates (once over 95% for referred cases), and deviation from statutory intent.
  • Director Squires aims to eliminate bias perceptions, centralize decisions, enhance transparency, and realign with the AIA's framework to support inventors and innovation.

The letter emphasizes restoring public trust in a fair, predictable patent system by separating institution from adjudication in post-grant patent proceedings.

Potential Impacts Compared to Current Practices

Currently, PTAB panels handle institutions, often resulting in high approval rates and criticisms of impartiality. With the USPTO Director deciding, there could be:

  • Lower Institution Rates: More rigorous thresholds, addressing "skewed" data and high invalidations, making it harder for weak petitions to proceed and strengthening patent quality.
  • Increased Accountability & Transparency: Single-point decisions reduce "referral-signal bias" and tie outcomes to the Director, a Senate-confirmed official.
  • Procedural Shifts: Petitioners may need stronger showings in IPR and PGR filings; expect updated guidance. This could slow proceedings but foster higher-quality challenges.
  • Broader Ecosystem Effects: Stronger patents might benefit smaller innovators, but challengers face hurdles. Legal or Congressional responses may follow.
  • Confidence vs. Political Bias Risks: Centralizing could boost confidence by enhancing transparency and eliminating self-interest, ensuring AIA adherence. However, as a Presidential appointee, decisions might be susceptible to political bias, influenced by administration priorities—highlighting need for additional oversight.

This "Back to the Future" step purports to realign the USPTO with the AIA's vision for innovation. What are your thoughts, IP pros? Will this change strengthen or complicate patent validity proceedings? Comment Below.